We're witnessing history in the making as MDMA is expected to be the first psychedelic approved by the FDA, potentially transforming how we treat mental health. This is a unique opportunity to hear from key figures deeply intertwined with MDMA's unlikely path from the dance floor to late-stage clinical trials to, potentially, the therapist's couch. We’ll take a captivating journey to explore just how this former party is making its way into so many of our lives as a uniquely therapeutic medicine.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.
Matthew Baggott, PhD
Tactogen
Julie Holland
MAPS / Palo Santo / Beckley
Rachel Nuwer
Freelance Journalist
Tim Schlidt
Palo Santo